131.53MMarket Cap-1.00P/E (TTM)
11.000High9.540Low103.26KVolume10.650Open10.830Pre Close1.03MTurnover5.72%Turnover RatioLossP/E (Static)13.34MShares19.99952wk High1.00P/B17.81MFloat Cap9.54052wk Low--Dividend TTM1.81MShs Float171.799Historical High--Div YieldTTM13.48%Amplitude9.540Historical Low9.951Avg Price1Lot Size
OnKure Therapeutics Stock Forum
Onkure Therapeutics Inc - Oki-219 Well Tolerated With No Hyperglycemia and Only Grade 1 Traes
SC 13G: Statement of acquisition of beneficial ownership by individuals-Kenneth Griffin(9.9%),Citadel Advisors LLC(9.8%), etc.
SEC 17:29
SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Asset Management, LP(14.98%),Bihua Chen(14.98%), etc.
SEC 16:24
SC 13G: Statement of acquisition of beneficial ownership by individuals-Samsara BioCapital, L...
No comment yet